Latest Estrogen Stories
A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant.
Dr. Rowan Chlebowski, MD, PhD, Los Angeles Biomedical Research Institute lead researcher and author of a study released March 29 by the Journal of the National Cancer Institute, issued the following statement regarding the latest findings from the Women's Health Initiative, the largest-ever study of hormonal therapy in post-menopausal women.
Estrogen plus progestin use is linked with increased breast cancer incidence.
Researchers at the Mayo Clinic Cancer Center have identified new DNA sequences associated with breast and ovarian cancers that help reveal the underlying causes of these diseases so new prevention strategies can be devised.
A new study has identified a set of genes that may predict which women are at high risk for getting breast cancer that is sensitive to estrogen. These women maybe also helped by taking drugs to prevent the cancer's development.
Oral estrogen therapy for menopausal women is associated with an increased risk of gallbladder surgery.
A Food and Drug Administration advisory committee rejected on Monday two proposed menopause drugs designed to reduce the frequency and severity of hot flashes.
A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.
More Images (1 images) »